InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Masson-Hurlburt Elizabeth, Chief Operating Officer. Officer active across 1 company, notably CorMedix Inc.. Cumulatively, 3 reports have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €91k. History available since 21 May 2021. The latest transaction was disclosed on 12 January 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations3 total
50,000 shares0Common StockSEC:0000929638-24-000134:0
8,000 shares@ US$6.92420.0049% mcap50.0% of flowCommon StockSEC:0001213900-21-029080:0
8,000 shares@ US$6.924250.0% of flowCommon StockSEC:0001213900-21-029080
3 of 3 declarations
About Masson-Hurlburt Elizabeth
Elizabeth Masson-Hurlburt is the Executive Vice President and Head of Clinical Operations at CorMedix Inc. She is responsible for overseeing clinical operations, ensuring that trials and studies meet quality and compliance standards. Her expertise is essential for the development of new treatments.
